LRRK2 Loss-of-Function Variants in Patients with Rare Diseases: No Evidence for a Phenotypic Impact

Mov Disord. 2021 Apr;36(4):1029-1031. doi: 10.1002/mds.28452. Epub 2021 Jan 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics
  • Protein Serine-Threonine Kinases*
  • Rare Diseases*

Substances

  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases